Thinking outside of the box 

I will review cases where the Hahnemannian practice of homoeopathy is not effective and one must think of other approaches to help the patient. I’ll discuss the use of taxonomical groupings, bowel nosodes and other forms of practice which lie outside the 'classical' practice of homoeopathy. 

Kim Elia is a renowned homoeopath, educator, historian and international speaker. While considering himself a life-long student he has been sharing homoeopathy with a worldwide audience for 32 years.

Kim was inspired to study homoeopathy when he read Gandhi’s quote, ‘Homeopathy cures a greater percentage of cases than any other method of treatment. Homeopathy is the latest and most refined method of treating patients economically and non-violently.’

After graduation, Kim went into clinical practice with Dr Paul Herscu and also specialised in nutritional therapy.

Since the early 2000s, Kim has been the CEO of WholeHealthNow, a comprehensive informational online resource for students and professionals. He was inspired to create the Historic Homeopathic Timeline and is responsible for a growing library of recorded interviews and presentations with today’s world renowned homoeopaths on a variety of timely and relevant topics. Kim also provides and coordinates training and support for homoeopathic software and oversees new software development with an international team of homoeopaths and software developers. He is the principal instructor and developer of the four-year classical homoeopathy program at the Hahnemann Academy in Tokyo and Osaka, Japan.

Kim is known for his dynamic and distinctive teaching methods which reflect his immense knowledge and deep understanding of remedies and practice. Kim’s intent is to bring the homoeopathic community together and to contribute to the training of effective practitioners who will bring homoeopathic medicine forward into the mainstream. 

Homoeoprophylaxis as an approach for assisting epidemic control: experiences from Cuba large scale applications 

 

 

 

As vice president of the Finlay Institute in Havana, Cuba, Dr Gustavo Bracho led several projects on basic research and their large-scale homoeoprophylaxis interventions from 2007 to 2015.

Gustavo finished his degree in Biochemistry in 1997 at Havana University, Cuba. He started his professional career as a researcher at the Research & Development Division of Finlay Institute, a world-renowned centre for vaccine research and production in Havana, Cuba where he completed his PhD degree in Molecular Immunology in 2004. In the same year he became the Head of the Adjuvant Group within the Immunology Department.

From 1997 to 2007, Gustavo worked on basic research and development of novel vaccines and adjuvants. In 2007 he was appointed as Advisor to the President and General Director of Finlay Institute and in 2008 to Head of the Natural Product Research and Development Division.

Gustavo’s expertise comprises multiple fields including immunology, vaccinology, molecular and cellular biology, data analysis, epidemiology, nanoparticles and ultra-dilutions. He also has experience in setting up and managing Good Manufacturing Practice (GMP) facilities. 

He now lives in Australia and is currently working on a number of projects including nanoparticles and ultra-dilutions.